Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
British Journal of Haematology|March 1, 2024
Smouldering multiple myeloma: To seek or not to seek? To treat or not to treat. That is the questionIuliana Vaxman, Moshe E GattBritish Journal of Haematology|January 9, 2013
Light chain amyloidosis 2012: a new eraMoshe E Gatt, Giovanni PalladiniThrombosis and Haemostasis|February 26, 2004
Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients? Results of a historical-cohort studyMoshe E Gatt, Ora Paltiel, Michael BursztynInternational Journal of Colorectal Disease|November 18, 2003
Prolonged ileus as a sole manifestation of pseudomembranous enterocolitisEran Elinav, David Planer, Moshe E GattLeukemia & Lymphoma|May 2, 2022
Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphomaEyal Lebel, Neta Goldschmidt, Tali Siegal, et al.Oncotarget|September 20, 2019
The role of CD24 in multiple myeloma tumorigenicity and effects of the microenvironment on its expressionNechama Gilad, Hila Zukerman, Marjorie Pick, et al.European Journal of Haematology|February 19, 2013
Increased risk of central venous catheter-associated thrombosis in acute promyelocytic leukemia: a single-institution experienceSigal Grisariu, Galia Spectre, Yosef Kalish, et al.Cancers|April 27, 2024
Immune Therapies in AL Amyloidosis-A Glimpse to the FutureArnon Haran, Iuliana Vaxman, Moshe E Gatt, et al.Cancer Chemotherapy and Pharmacology|August 3, 2013
Short communication: bendamustine-related hemolytic anemia in chronic lymphocytic leukemiaNeta Goldschmidt, Alexander Gural, Dina Ben-Yehuda, et al.Acta Haematologica|October 22, 2018
A Bortezomib-Based Protocol Induces a High Rate of Complete Remission with Minor Toxicity in Adult Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaBoaz Nachmias, Adir Shaulov, Moshe E Gatt, et al.Pageof 9